Regulation of circulating fibroblast growth factor-23 by parathyroid hormone in patients with primary hyperparathyroidism

被引：0
|
作者：
Kurajoh, Masafumi [1 ]
Imanishi, Yasuo [1 ]
Kobayashi, Keisuke [1 ]
Ishii, Akira [1 ]
Nagata, Tomoki [1 ]
Inaba, Masaaki [1 ]
Miki, Takami [1 ]
Nishizawa, Yoshiki [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [21] Regulation of fibroblast growth factor-23 in chronic kidney disease
    Westerberg, Per-Anton
    Linde, Torbjoern
    Wikstroem, Bjoern
    Ljunggren, Oesten
    Stridsberg, Mats
    Larsson, Tobias E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3202 - 3207
  • [22] Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
    Nakanishi, S
    Kazama, JJ
    Nii-Kono, T
    Omori, K
    Yamashita, T
    Fukumoto, S
    Gejyo, F
    Shigematsu, T
    Fukagawa, M
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 1171 - 1178
  • [23] Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
    Mirza, Majd A. I.
    Larsson, Anders
    Lind, Lars
    Larsson, Tobias E.
    ATHEROSCLEROSIS, 2009, 205 (02) : 385 - 390
  • [24] Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
    Andrukhova, Olena
    Slavic, Svetlana
    Odoerfer, Kathrin I.
    Erben, Reinhold G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (10) : 1831 - 1839
  • [25] Fibroblast Growth Factor 23, but not Parathyroid Hormone, Is Associated With Urinary Phosphate Regulation in Patients on Peritoneal Dialysis
    Yamada, Shunsuke
    Tsuruya, Kazuhiko
    Tokumoto, Masanori
    Yoshida, Hisako
    Hasegawa, Shoko
    Tanaka, Shigeru
    Eriguchi, Masahiro
    Nakano, Toshiaki
    Masutani, Kosuke
    Ooboshi, Hiroaki
    Kitazono, Takanari
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (01) : 73 - 80
  • [26] Fibroblast growth factor 23, parathyroid hormone, and 1α,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
    Tebben, P
    Clarke, BL
    Singh, RJ
    Kumar, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S185 - S185
  • [27] FIBROBLAST GROWTH FACTOR-23 AND PARATHYROID HORMONE PREDICT THE EXTENT OF AORTIC VALVE CALCIFICATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Di Lullo, Luca
    Russo, Domenico
    Gorini, Antonio
    Ronco, Claudo
    Santoboni, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [28] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    M. Sridharan
    J. Cheung
    A. E. Moore
    M. L. Frost
    W. D. Fraser
    I. Fogelman
    G. Hampson
    Calcified Tissue International, 2010, 87 : 398 - 405
  • [29] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    Geeta Hampson
    Calcified Tissue International, 2011, 88
  • [30] Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
    Lopez, Ignacio
    Encarnacion Rodriguez-Ortiz, M.
    Almaden, Yolanda
    Guerrero, Fatima
    Montes de Oca, A.
    Pineda, Carmen
    Shalhoub, Vicky
    Rodriguez, Mariano
    Aguilera-Tejero, Escolastico
    KIDNEY INTERNATIONAL, 2011, 80 (05) : 475 - 482
12345